Gene · 104
Papers2,137
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,137
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Pattern of RNA Editing Changes in Pleural Mesothelioma upon Epithelial-Mesenchymal Transition. | Int J Mol Sci | 2023 | 36769192 | PubTator, text mining | PubMed |
| The Repertoire of RNA Modifications Orchestrates a Plethora of Cellular Responses. | Int J Mol Sci | 2023 | 36768716 | PubTator, text mining | PubMed |
| Integrated analysis of RNA methylation regulators crosstalk and immune infiltration for predictive and personalized therapy of diabetic nephropathy. | Hum Genomics | 2023 | 36765416 | PubTator, text mining | PubMed |
| Mechanism of Calcium Permeation in a Glutamate Receptor Ion Channel. | J Chem Inf Model | 2023 | 36758214 | PubTator, text mining | PubMed |
| ADAR1 and ZBP1 in innate immunity, cell death, and disease. | Trends Immunol | 2023 | 36710220 | PubTator, text mining | PubMed |
| Programmable macromolecule-based RNA-targeting therapies to treat human neurological disorders. | RNA | 2023 | 36693761 | PubTator, text mining | PubMed |
| Nucleoside analogs in ADAR guide strands targeting 5'-UA̲ sites. | RSC Chem Biol | 2023 | 36685257 | PubTator, text mining | PubMed |
| Meiotic chromosome organization and its role in recombination and cancer. | Curr Top Dev Biol | 2023 | 36681479 | PubTator, text mining | PubMed |
| mRNA Metabolism and Hypertension. | Biomedicines | 2023 | 36672629 | PubTator, text mining | PubMed |
| Site-directed A → I RNA editing as a therapeutic tool: moving beyond genetic mutations. | RNA | 2023 | 36669890 | PubTator, text mining | PubMed |
| The Interplay between RNA Editing Regulator ADAR1 and Immune Environment in Colorectal Cancer. | J Oncol | 2023 | 36660243 | PubTator, text mining | PubMed |
| Gene Modulation with CRISPR-based Tools in Human iPSC-Cardiomyocytes. | Stem Cell Rev Rep | 2023 | 36656467 | PubTator, text mining | PubMed |
| Assessing and advancing the safety of CRISPR-Cas tools: from DNA to RNA editing. | Nat Commun | 2023 | 36639728 | PubTator, text mining | PubMed |
| The interferon stimulated gene-encoded protein HELZ2 inhibits human LINE-1 retrotransposition and LINE-1 RNA-mediated type I interferon induction. | Nat Commun | 2023 | 36639706 | PubTator, text mining | PubMed |
| RNA editing: Expanding the potential of RNA therapeutics. | Mol Ther | 2023 | 36620962 | PubTator, text mining | PubMed |
| Proteomics-based determination of double-stranded RNA interactome reveals known and new factors involved in Sindbis virus infection. | RNA | 2023 | 36617674 | PubTator, text mining | PubMed |
| ADAR1-dependent miR-3144-3p editing simultaneously induces MSI2 expression and suppresses SLC38A4 expression in liver cancer. | Exp Mol Med | 2023 | 36599932 | PubTator, text mining | PubMed |
| Pathological features of glial cells and motor neurons in the anterior horn of the spinal cord in sporadic ALS using ADAR2 conditional knockout mice. | J Neurol Sci | 2023 | 36527980 | PubTator, text mining | PubMed |
| Single-Cell Analysis in Lung Adenocarcinoma Implicates RNA Editing in Cancer Innate Immunity and Patient Prognosis. | Cancer Res | 2023 | 36449563 | PubTator, text mining | PubMed |
| The miR-124-AMPAR pathway connects polygenic risks with behavioral changes shared between schizophrenia and bipolar disorder. | Neuron | 2023 | 36379214 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/104/papers?page=15